Abstract
The use of Intense Pulsed Light (IPL) therapy in the treatment of a variety of dermatologic conditions has increased in use since the early 1990’s. In particular, it has become more popular in the treatment of disorders of chronic venous insufficiency, including reticular veins and telangiectasias. In the past, sclerotherapy and traditional lasers had been used for this purpose, however these procedures may leave patients with adverse long-term effects. The IPL source emits light from a wide spectrum of wavelengths but use of selective cut-off filters allows safe and effective treatment according to an individual’s skin type. This helps reduce adverse effects such as blistering, erythema, and burns that are commonly seen when traditional therapy is used. When proper patient selection and methodology is implemented, IPL has proven to be a successful alternative to traditional therapies and has been very effective, specifically for their use in treatment of facial telangiectasias. Further studies need to be done to elucidate their effects in the treatment of reticular veins alone, however the few studies that have been done are promising.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ruckley C, Evans C, Allan P, Lee A, Fowkes F. Telangiectasia in the Edinburgh vein study: epidemiology and association with trunk varices and symptoms. Eur J Vasc Endovasc Surg. 2008;36:719–24.
Nakano LC, Cacione DG, Baptista-Silva JC, Flumignan RL. Treatment for telangiectasias and reticular veins. Cochrane Database Syst Rev. 2017;2017:CD012723. https://doi.org/10.1002/14651858.CD012723.
Hercogova J, Brazzini B, Hautmann G, Ghersetich I, Lotti T. Laser treatment of cutaneous vascular lesions: face and leg telangiectases. J Eur Acad Dermatol Venereol. 2002;16:12–8.
Porter JM, Moneta GL, on Chronic AICC, Disease V. Reporting standards in venous disease: an update. J Vasc Surg. 1995;21:635–45.
Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175–84.
Engel A, Johnson M-L, Haynes SG. Health effects of sunlight exposure in the United States: results from the first National Health and nutrition examination survey, 1971-1974. Arch Dermatol. 1988;124:72–9.
Callam M. Epidemiology of varicose veins. Br J Surg. 1994;81:167–73.
Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–52.
Green D. Reticular veins, incompetent reticular veins, and their relationship to telangiectases. Dermatol Surg. 1998;24:1129–41.
Weiss RA, Weiss MA. Doppler ultrasound findings in reticular veins of the thigh subdermic lateral venous system and implications for sclerotherapy. J Dermatol Surg Oncol. 1993;19:947–51.
Somjen GM, Ziegenbein R, Johnston AH, Royle JP. Anatomical examination of leg telangiectases with duplex scanning. J Dermatol Surg Oncol. 1993;19:940–5.
Astner S, Anderson RR. Treating vascular lesions. Dermatol Ther. 2005;18:267–81.
Kauvar AN, Lou WW. Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol. 2000;136:1371–5.
West TB, Alster TS. Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24:221–6.
Babilas P, Schreml S, Szeimies RM, Landthaler M. Intense pulsed light (IPL): a review. Lasers Surg Med. 2010;42:93–104.
DiBernardo BE, Pozner JN. Intense pulsed light therapy for skin rejuvenation. Clin Plast Surg. 2016;43:535–40.
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–71.
Goldman MP, Eckhouse S, ESC MEDICAL SYSTEMS LPVCSG. Photothermal sclerosis of leg veins. Dermatol Surg. 1996;22:323–30.
Raulin C, Hellwig S, Schönermark MP. Treatment of a nonresponding port-wine stain with a new pulsed light source (PhotoDerm® VL). Lasers Surg Med. 1997;21:203–8.
Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cutan Laser Ther. 2001;3:169–73.
Retamar R, Chames C, Pellerano G. Treatment of linear and spider telangiectasia with an intense pulsed light source. J Cosmet Dermatol. 2004;3:187–90.
Clementoni MT, Gilardino P, Muti GF, Signorini M, Pistorale A, Morselli PG, et al. Intense pulsed light treatment of 1,000 consecutive patients with facial vascular marks. Aesthet Plast Surg. 2006;30:226–32.
Clementoni MT, Gilardino P, Muti GF, Signorini M, Pistorale A, Morselli PG, et al. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med. 2005;37:9–13.
Tanghetti EA. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med. 2012;44:97–102.
Fodor L, Ramon Y, Fodor A, Carmi N, Peled IJ, Ullmann Y. A side-by-side prospective study of intense pulsed light and Nd: YAG laser treatment for vascular lesions. Ann Plast Surg. 2006;56:164–70.
Sadick NS. A dual wavelength approach for laser/intense pulsed light source treatment of lower extremity veins. J Am Acad Dermatol. 2002;46:66–72.
Colaiuda S, Colaiuda F, Gasparotti M. Treatment of deep underlying reticular veins by Nd: Yag laser and IPL source. Minerva Cardioangiol. 2000;48:329–34.
Nymann P, Hedelund L, Hædersdal M. Intense pulsed light vs. long-pulsed dye laser treatment of telangiectasia after radiotherapy for breast cancer: a randomized split-lesion trial of two different treatments. Br J Dermatol. 2009;160:1237–41.
Murray A, Moore T, Richards H, Ennis H, Griffiths C, Herrick A. Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectases. Br J Dermatol. 2012;167:563–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Multiple Choice Questions
Multiple Choice Questions
12.1.1 Q1: True or False, IPL Is Safer and More Efficacious in Facial Versus Leg Veins
-
(a)
True
-
(b)
False
12.1.2 Q2: The Type of Light IPL Produces Is
-
(a)
Noncoherent, polychromatic light
-
(b)
Coherent, polychromatic light
-
(c)
Noncoherent, monochromatic light
-
(d)
Coherent, monochromatic light
12.1.3 Q3: True or False, Reticular Veins and Telangiectasias Are a Symptom of Chronic Venous Insufficiency
-
(a)
True
-
(b)
False
12.1.4 Q4: IPL and Lasers for Leg Telangiectasias/Reticular Veins Are an Alternative to
-
(a)
Endovenous laser ablation
-
(b)
Sclerotherapy
-
(c)
Endovenous radiofrequency ablation
-
(d)
All of the above
12.1.5 Q5: True or False, Telangiectasias and Reticular Veins Always Coexist
-
(a)
True
-
(b)
False
12.1.6 Q6: What Is the Preferred Wavelength for Treating a Leg Telangiectasias/Reticular Veins
-
(a)
1200 nm
-
(b)
755 nm
-
(c)
580 nm
-
(d)
860 nm
12.1.7 Q7: Common Adverse Events Associated with IPL Include
-
(a)
Burns
-
(b)
Blisters
-
(c)
Discoloration
-
(d)
All of the above
12.1.8 Q8: True or False, IPL Is Safe for All Skin Types
-
(a)
True
-
(b)
False
12.1.9 Q9: True or False, IPL Can Be Combined with Lasers and/or Sclerotherapy
-
(a)
True
-
(b)
False
12.1.10 Q10: When Treating a Patient with IPL, the Ideal Treatment Interval Is:
-
(a)
Twice a week
-
(b)
Once a month
-
(c)
As needed
-
(d)
Annually
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Golpanian, R.S., Dorizas, A., Sadick, N. (2020). Intense-Pulsed Light (IPL) for Telengiectasia and Reticular Veins. In: Fodor, L., Ullmann, Y. (eds) Aesthetic Applications of Intense Pulsed Light. Springer, Cham. https://doi.org/10.1007/978-3-030-22829-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-22829-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22828-6
Online ISBN: 978-3-030-22829-3
eBook Packages: MedicineMedicine (R0)